Real-world risk of bleeding events in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) treated with BTKi

被引:0
|
作者
Moslehi, Javid J.
Wahlstrom, Svea K.
Teschemaker, Anna
Mackey, Rachel H.
DeVincenzo, Diana
Carabuena, Leslie A.
Thompson, Samantha L.
Gordon, Brittaney
Rosenthal, Ning A.
机构
[1] Univ Calif San Francisco, Sect Cardiooncol & Immunol, San Francisco, CA USA
[2] AstraZeneca, Wilmington, DE USA
[3] AstraZeneca, Gaithersburg, MD USA
[4] Premier In, PINC AI Appl Sci, Charlotte, NC USA
[5] AstraZeneca, Cambridge, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7052
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Pathology Quiz Case 1 Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) of the LDS
    Van Abel, Kathryn M.
    Bilyk, Jurij R.
    Bourne, Scott E.
    Ezzat, Waleed H.
    Finden, Steven G.
    Pribitkin, Edmund A.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2010, 136 (10) : 1037 - +
  • [32] Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance
    St-Pierre, Frederique
    Ma, Shuo
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2022, 12 : 81 - 98
  • [33] Outcomes of hematopoietic stem cell transplantation for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
    Dickinson, John D.
    Loberiza, Fausto
    Whalen, Victoria
    Bierman, Philip J.
    Vose, Julie M.
    Devetten, Marcel P.
    Maness, Lori J.
    Armitage, James O.
    Bociek, Greg
    BLOOD, 2007, 110 (11) : 894A - 895A
  • [34] The spectrum of coincident entities with small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) diagnosed by cytology
    Kastenbaum, Hannah A.
    Khalbuss, Walid E.
    Felgar, Raymond E.
    Stoller, Ronald
    Monaco, Sara E.
    CYTOJOURNAL, 2010, 7
  • [35] A Phase II study of intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/ small lymphocytic lymphoma (CLL/SLL)
    Shouse, Geoffrey
    Chen, Lu
    Siddiqi, Tanya
    Muir, Alex
    Brown, Jennifer
    Spurgeon, Stephen
    Danilov, Alexey
    LEUKEMIA & LYMPHOMA, 2023, 64 : S105 - S106
  • [36] Rituximab as first-line and maintenance therapy for patients with small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL).
    Hainsworth, JD
    Litchy, S
    Burris, HA
    Greco, FA
    BLOOD, 2001, 98 (11) : 363A - 363A
  • [37] A Phase II Study of Intermittent Duvelisib Dosing in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Shouse, Geoffrey P.
    Chen, Lu
    Siddiqi, Tanya
    Muir, Alex
    Brown, Jennifer R.
    Spurgeon, Stephen E.
    Danilov, Alexey
    BLOOD, 2023, 142
  • [38] Primary cutaneous lymphomas in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A series of 12 cases
    Liu, Yi Ariel
    Finn, Alexander J.
    Subtil, Antonio
    JOURNAL OF CUTANEOUS PATHOLOGY, 2021, 48 (05) : 617 - 624
  • [39] "Accelerated" chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): unraveling the biological gray zone of CLL/SLL in the era of novel therapies
    Vadasz, Brian
    Zak, Taylor
    Aldinger, Jonathan
    Sukhanova, Madina
    Gao, Juehua
    Wolniak, Kristy Lucile
    Chen, Yi-Hua
    Chen, Qing Ching
    Ma, Shuo
    Tariq, Hamza
    VIRCHOWS ARCHIV, 2024,
  • [40] Insights From the informCLL Registry: Real-World Application of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Ghosh, Nilanjan
    Brander, Danielle
    Mato, Anthony R.
    Sharman, Jeff P.
    Gutierrez, Meghan
    Naganuma, Maoko
    Upasani, Sandhya
    Alagappan, Divi
    Huang, Qing
    Young, Alex
    Barrientos, Jacqueline C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S317 - S317